What is the Y-tunnus number of Fisher & Paykel Healthcare AB, filial i Finland?

Fisher & Paykel Healthcare AB, filial i Finland is registered with PRH / YTJ under Y-tunnus 2626342-3.

Who is the CEO of Fisher & Paykel Healthcare AB, filial i Finland?

James Peter Tuck is Person with significant control of Fisher & Paykel Healthcare AB, filial i Finland, in role since 2025.

Fisher & Paykel Healthcare AB, filial i Finland's registered address is Mannerheimintie 12-B.

SLActive

Y-tunnus 2626342-3Mannerheimintie 12B, 00100 HelsinkiActivities of agents involved in the wholesale of other particular products · NACE 4618Est. 2014 · 11 years old— employees

Actively employed in the business

Name	Role	Member since
Current (9)
JP James Peter Tuck Person with significant control	Person with significant control	2025
JP Justin Peter Callahan Person with significant control	Person with significant control	2025
RA Rene Arjan Murk Foreign representative	Foreign representative	2025
AJ Amelia Johansson Foreign representative	Foreign representative	2025
AH Amanda Helen Pettersson Foreign representative	Foreign representative	2025
PS Patrick Sean McSweeney Foreign representative	Foreign representative	2016
CE Carl Eric Oscar Ingelmark Foreign representative	Foreign representative	2025
RA René Arjan Murk Person with significant control	Person with significant control	2016
DP Douglas Peter Nielsen Person with significant control	Person with significant control	2025
Former (5)
IM Ian Micahel Hopkinson Foreign representative	Foreign representative	2016 – 2021
LG Lewis George Gradon Foreign representative	Foreign representative	2016 – 2025
EL Eva Linnéa Elisabeth Sten Person with significant control	Person with significant control	2016 – 2025
PN Paul Nigel Shearer Foreign representative	Foreign representative	2016 – 2025
PB Philippe Berardi Foreign representative	Foreign representative	2021 – 2025

Non-executive oversight

No data on file.

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.